SARS-CoV-2 spike-specific IgG4 class switching associates with clinical recovery in Long COVID - 17/11/25
Doi : 10.1016/j.jinf.2025.106641
Kaori Sano
Influenza Research Center, National Institute of Infectious Diseases, Japan Institute for Health Security, Tokyo, Japan
Yayoi Kimura ⁎ 
Advanced Medical Research Center, Yokohama City University, Kanagawa, Japan
Emerging Infectious Diseases Research Center, Advanced Medical Research Center, Yokohama City University, Kanagawa, Japan
∗ Correspondence to: Emerging Infectious Diseases Research Center, Advanced Medical Research Center, Yokohama City University, 3-9 Fukuura, Kanazawa, Yokohama, Kanagawa 236-0004, Japan. Emerging Infectious Diseases Research Center, Advanced Medical Research Center, Yokohama City University 3-9 Fukuura, Kanazawa Yokohama Kanagawa 236-0004 Japan
Hideaki Kato
Infection Prevention and Control Department, Yokohama City University Hospital, Kanagawa, Japan
Emerging Infectious Diseases Research Center, Advanced Medical Research Center, Yokohama City University, Kanagawa, Japan
Hideki Hasegawa
Influenza Research Center, National Institute of Infectious Diseases, Japan Institute for Health Security, Tokyo, Japan
Institute for Vaccine Research and Development, Hokkaido University, Sapporo, Japan
Hidenori Akutsu
Center for Regenerative Medicine, National Center for Child Health and Development, Tokyo, Japan
Akihide Ryo
Department of Bioinformatics and Integrative Omics, National Institute of Infectious Diseases, Japan Institute for Health Security, Tokyo, Japan
Department of Microbiology, Yokohama City University School of Medicine, Kanagawa, Japan
Atsushi Goto ⁎
Department of Public Health, Yokohama City University School of Medicine, Kanagawa, Japan
Department of Health Data Science, Graduate School of Data Science, Yokohama City University, Kanagawa, Japan
Emerging Infectious Diseases Research Center, Advanced Medical Research Center, Yokohama City University, Kanagawa, Japan
∗∗ Correspondence to: Department of Public Health, Yokohama City University School of Medicine, 3-9 Fukuura, Kanazawa, Yokohama, Kanagawa 236-0004, Japan. Department of Public Health, Yokohama City University School of Medicine 3-9 Fukuura, Kanazawa Yokohama Kanagawa 236-0004 Japan
Kei Miyakawa ⁎
Influenza Research Center, National Institute of Infectious Diseases, Japan Institute for Health Security, Tokyo, Japan
Department of Microbiology, Yokohama City University School of Medicine, Kanagawa, Japan
AIDS Research Center, National Institute of Infectious Diseases, Tokyo, Japan
∗∗∗ Correspondence to: Influenza Research Center, National Institute of Infectious Diseases, Japan Institute for Health Security, 4-7-1 Gakuen, Musashimurayama, Tokyo 208-0011, Japan. Influenza Research Center, National Institute of Infectious Diseases, Japan Institute for Health Security 4-7-1 Gakuen Musashimurayama Tokyo 208-0011 Japan
Bienvenue sur EM-consulte, la référence des professionnels de santé.
Article gratuit.
Connectez-vous pour en bénéficier!
Le texte complet de cet article est disponible en PDF.
Plan
© 2025
The Author(s). Publié par Elsevier Masson SAS. Tous droits réservés.
Vol 91 - N° 5
Article 106641- novembre 2025 Retour au numéro
Article précédent
- Emergence of a high-risk Enterobacter hormaechei ST78 clone from hospital wastewater co-harboring blaNDM-4, tmexCD2-toprJ2, and mcr-9.2: Convergence of last-resort antimicrobial resistance genes
- Hao Guo, Nanqi Zhang, Qiao Li, Yawen Zhang, Wenping Lin, Fang He
- Real-world utility of antigen-based testing (LumiraDX) for SARS-CoV-2 and influenza A/B in an acute hospital emergency care setting: a useful triage tool
- David Crawford-Jones, Maisy Charlett, Louise Downs, Katie Jeffery
Bienvenue sur EM-consulte, la référence des professionnels de santé.